107 related articles for article (PubMed ID: 1200773)
1. Marijuana consumption and tolerance to physiological and subjective effects.
Babor TF; Mendelson JH; Greenberg I; Kuehnle JC
Arch Gen Psychiatry; 1975 Dec; 32(12):1548-52. PubMed ID: 1200773
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute and chronic inhalation of hashish, marijuana, and delta 9-tetrahydrocannabinol on brain electrical activity in man: evidence for tissue tolerance.
Fink M
Ann N Y Acad Sci; 1976; 282():387-98. PubMed ID: 1071390
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
[TBL] [Abstract][Full Text] [Related]
4. Social effects of marijuana use in a recreational setting.
Babor TF; Mendelson JH; Uhly B; Kuehnle JC
Int J Addict; 1978 Aug; 13(6):947-59. PubMed ID: 730405
[TBL] [Abstract][Full Text] [Related]
5. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users.
Vadhan NP; Hart CL; van Gorp WG; Gunderson EW; Haney M; Foltin RW
J Clin Exp Neuropsychol; 2007 May; 29(4):357-64. PubMed ID: 17497559
[TBL] [Abstract][Full Text] [Related]
7. Effects of delta 9-THC on marijuana smoking, dose choice, and verbal report of drug liking.
Kelly TH; Foltin RW; Emurian CS; Fischman MW
J Exp Anal Behav; 1994 Mar; 61(2):203-11. PubMed ID: 8169569
[TBL] [Abstract][Full Text] [Related]
8. Tolerance to the respiratory effects of marijuana in man.
Bellville JW; Gasser JC; Miyake T; Aqleh K
J Pharmacol Exp Ther; 1976 May; 197(2):326-31. PubMed ID: 1271283
[TBL] [Abstract][Full Text] [Related]
9. Responses to oral delta9-tetrahydrocannabinol in frequent and infrequent marijuana users.
Kirk JM; de Wit H
Pharmacol Biochem Behav; 1999 May; 63(1):137-42. PubMed ID: 10340534
[TBL] [Abstract][Full Text] [Related]
10. Marijuana: dose effects on pulse rate, subjective estimates of intoxication, free recall and recognition memory.
Miller LL; Cornett TL
Pharmacol Biochem Behav; 1978 Nov; 9(5):573-7. PubMed ID: 733845
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing marijuana self-administration by humans.
Haney M; Comer SD; Ward AS; Foltin RW; Fischman MW
Behav Pharmacol; 1997 Jun; 8(2-3):101-12. PubMed ID: 9833006
[TBL] [Abstract][Full Text] [Related]
12. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
Manno JE; Manno BR; Kemp PM; Alford DD; Abukhalaf IK; McWilliams ME; Hagaman FN; Fitzgerald MJ
J Anal Toxicol; 2001 Oct; 25(7):538-49. PubMed ID: 11599597
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
14. Effects of delta9-tetrahydrocannabinol and cannabinol in man.
Karniol IG; Shirakawa I; Takahashi RN; Knobel E; Musty RE
Pharmacology; 1975; 13(6):502-12. PubMed ID: 1221432
[TBL] [Abstract][Full Text] [Related]
15. Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis.
Khiabani HZ; Mørland J; Bramness JG
Eur J Intern Med; 2008 Dec; 19(8):608-12. PubMed ID: 19046727
[TBL] [Abstract][Full Text] [Related]
16. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction.
Dhawan K; Kumar S; Sharma A
J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005
[TBL] [Abstract][Full Text] [Related]
17. Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures.
Heishman SJ; Huestis MA; Henningfield JE; Cone EJ
Pharmacol Biochem Behav; 1990 Nov; 37(3):561-5. PubMed ID: 1965045
[TBL] [Abstract][Full Text] [Related]
18. Phytohemagglutinin-induced lymphocyte transformation in humans receiving delta9-tetrahydrocannabinol.
Lau RJ; Tubergen DG; Barr M; Domino EF; Benowitz N; Jones RT
Science; 1976 May; 192(4241):805-7. PubMed ID: 1265484
[TBL] [Abstract][Full Text] [Related]
19. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW
Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
[TBL] [Abstract][Full Text] [Related]
20. Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration.
Newmeyer MN; Swortwood MJ; Abulseoud OA; Huestis MA
Drug Alcohol Depend; 2017 Jun; 175():67-76. PubMed ID: 28407543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
